论文部分内容阅读
目的探讨心源性脑栓塞患者采用注射用尤瑞克林治疗的效果及其对神经功能的影响。方法所选研究对象为2016年2月至2017年2月沈阳市第四人民医院收治的86例心源性脑栓塞患者,将其按照1:1比例随机分为研究组(注射用尤瑞克林)与对照组(常规对症治疗)。比较两组患者临床疗效、神经功能缺损程度变化情况及并发症发生情况。结果研究组、对照组患者治疗的总有效率分别为97.7%、83.7%,差异有统计学意义(P<0.05);治疗后,研究组患者美国国立卫生研究院卒中量表(NIHSS)评分明显低于对照组,差异有统计学意义(P<0.05);研究组、对照组并发症发生率分别为4.7%、7.0%,差异无统计学意义(P>0.05)。结论在心源性脑栓塞患者的临床治疗过程中,于常规对症治疗基础上,加用注射用尤瑞克林,能改善临床疗效,减轻神经功能缺损程度,且不会增加并发症发生风险。
Objective To investigate the effect of norepinephrine for injection on neurogenic function in patients with cardiogenic cerebral embolism. Methods The selected subjects were 86 patients with cardiogenic cerebral embolism who were admitted to the Fourth People’s Hospital of Shenyang from February 2016 to February 2017. The patients were randomly divided into study group (1: 1) Lin) and control group (conventional symptomatic treatment). Clinical efficacy, changes in neurological deficit and complication were compared between the two groups. Results The total effective rate of treatment in study group and control group was 97.7% and 83.7%, respectively, with significant difference (P <0.05). After treatment, the NIHSS score of study group was significantly higher (P <0.05). The complication rates of study group and control group were 4.7% and 7.0%, respectively, with no significant difference (P> 0.05). Conclusion In the clinical treatment of patients with cardiogenic cerebral embolism, the addition of uracil for injection on the basis of conventional symptomatic treatment can improve the clinical curative effect, reduce the degree of neurological deficit, and will not increase the risk of complications.